Keywords: fda, panel, rejects, pfizer, tenidap, application, long-awaited

FDA Panel Rejects Pfizer's Tenidap Application

Article | 13 May 1996

Print This

Pfizer's long-awaited drug for rheumatoid and osteoarthritis, Enable (tenidap) failed to secure a recommendation for approval by the US Food ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in